Cargando…
Managing drug shortages during a pandemic: tocilizumab and COVID-19
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177913/ https://www.ncbi.nlm.nih.gov/pubmed/33952621 http://dx.doi.org/10.1503/cmaj.210531 |
_version_ | 1783703474997821440 |
---|---|
author | Verma, Amol A. Pai, Menaka Saha, Sudipta Bean, Sally Fralick, Michael Gibson, Jennifer L. Greenberg, Rebecca A. Kwan, Janice L. Lapointe-Shaw, Lauren Tang, Terence Morris, Andrew M. Razak, Fahad |
author_facet | Verma, Amol A. Pai, Menaka Saha, Sudipta Bean, Sally Fralick, Michael Gibson, Jennifer L. Greenberg, Rebecca A. Kwan, Janice L. Lapointe-Shaw, Lauren Tang, Terence Morris, Andrew M. Razak, Fahad |
author_sort | Verma, Amol A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8177913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | CMA Joule Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81779132021-06-05 Managing drug shortages during a pandemic: tocilizumab and COVID-19 Verma, Amol A. Pai, Menaka Saha, Sudipta Bean, Sally Fralick, Michael Gibson, Jennifer L. Greenberg, Rebecca A. Kwan, Janice L. Lapointe-Shaw, Lauren Tang, Terence Morris, Andrew M. Razak, Fahad CMAJ Analysis CMA Joule Inc. 2021-05-25 /pmc/articles/PMC8177913/ /pubmed/33952621 http://dx.doi.org/10.1503/cmaj.210531 Text en © 2021 CMA Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Analysis Verma, Amol A. Pai, Menaka Saha, Sudipta Bean, Sally Fralick, Michael Gibson, Jennifer L. Greenberg, Rebecca A. Kwan, Janice L. Lapointe-Shaw, Lauren Tang, Terence Morris, Andrew M. Razak, Fahad Managing drug shortages during a pandemic: tocilizumab and COVID-19 |
title | Managing drug shortages during a pandemic: tocilizumab and COVID-19 |
title_full | Managing drug shortages during a pandemic: tocilizumab and COVID-19 |
title_fullStr | Managing drug shortages during a pandemic: tocilizumab and COVID-19 |
title_full_unstemmed | Managing drug shortages during a pandemic: tocilizumab and COVID-19 |
title_short | Managing drug shortages during a pandemic: tocilizumab and COVID-19 |
title_sort | managing drug shortages during a pandemic: tocilizumab and covid-19 |
topic | Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177913/ https://www.ncbi.nlm.nih.gov/pubmed/33952621 http://dx.doi.org/10.1503/cmaj.210531 |
work_keys_str_mv | AT vermaamola managingdrugshortagesduringapandemictocilizumabandcovid19 AT paimenaka managingdrugshortagesduringapandemictocilizumabandcovid19 AT sahasudipta managingdrugshortagesduringapandemictocilizumabandcovid19 AT beansally managingdrugshortagesduringapandemictocilizumabandcovid19 AT fralickmichael managingdrugshortagesduringapandemictocilizumabandcovid19 AT gibsonjenniferl managingdrugshortagesduringapandemictocilizumabandcovid19 AT greenbergrebeccaa managingdrugshortagesduringapandemictocilizumabandcovid19 AT kwanjanicel managingdrugshortagesduringapandemictocilizumabandcovid19 AT lapointeshawlauren managingdrugshortagesduringapandemictocilizumabandcovid19 AT tangterence managingdrugshortagesduringapandemictocilizumabandcovid19 AT morrisandrewm managingdrugshortagesduringapandemictocilizumabandcovid19 AT razakfahad managingdrugshortagesduringapandemictocilizumabandcovid19 |